• US foreign aid has collapsed. How should philanthropy respond?

    US foreign aid has collapsed. How should philanthropy respond?

    Can philanthropy fill the gap left by the closure of USAID? Unlikely, say the experts — but it can do something. It’s been a deeply turbulent three weeks for foreign aid, with the abrupt dismantling of USAID sending shockwaves through the sector. Funding for lifesaving programs has evaporated overnight, leaving many to wonder whether foundations […]

  • Making Data Work: Strengthening Community-Led Monitoring in Ukraine & South Africa Webinar

    Making Data Work: Strengthening Community-Led Monitoring in Ukraine & South Africa Webinar

    On Wednesday, 12 February 2025, ITPC hosted a webinar exploring how Community-Led Monitoring (CLM) operates in diverse socio-economic and political contexts. Experts from HAC – Ukraine and NACOSA – South Africa shared insights on how CLM data is used for impactful change, transparency, and advocacy. This discussion highlighted the challenges and successes of CLM implementation. […]

  • South Africa’s HIV response in crisis as illegal US funding freeze pushes health system to the brink

    South Africa’s HIV response in crisis as illegal US funding freeze pushes health system to the brink

    The United States (US) government’s funding freeze is wreaking havoc across vital healthcare services in South Africa, creating an unprecedented crisis for people living with and affected by HIV and TB. A newly released compendium of frontline testimony by civil society exposes the deadly impact of halted support, with clinics shutting down, life-saving treatments interrupted […]

  • Making sense of the madness

    Making sense of the madness

    Understanding the Current Crisis and Opportunity in Global Public Health On Wednesday 5 February 2025, ITPC hosted a webinar with global health experts to discuss the current global health crisis, human rights, HIV science, development finance and community intelligence. Panelists: Solange Baptiste: Solange is the Executive Director of ITPC Global. With over 20 years of […]

  • Mpox: A Public Health Emergency Impacting Africa

    Mpox: A Public Health Emergency Impacting Africa

    Since 2022, Mpox has been reported in over 127 countries. On July 14, 2024, the World Health Organization (WHO) declared the ongoing Mpox outbreak a Public Health Emergency of International Concern (PHEIC). A day earlier, the Africa Centres for Disease Control and Prevention (Africa CDC) had declared it a Public Health Emergency of Continental Security […]

  • Summary Report on Community-Led Assessment of Access to Viral Load and Drug Resistance Testing in the Kyrgyz Republic and the Republic of Belarus

    Summary Report on Community-Led Assessment of Access to Viral Load and Drug Resistance Testing in the Kyrgyz Republic and the Republic of Belarus

    In 2023–2024, our partners in Kyrgyzstan and Belarus conducted an assessment of access to viral load and drug resistance testing. Our team has prepared a summary report based on data collected over the past year, providing an analysis of the current situation in both countries. The report includes information on the availability of viral load […]

  • Access for everyone, everywhere

    Access for everyone, everywhere

    The title of the UniversalDeclaration of Human Rightsmakes it clear. Our rights areuniversal. When it comes tothese rights, no one is excluded.Yet, when it comes to access tomedicines and other essentialhealth tools, the world has yet torecognize the universality of ourrights. People are denied accessto affordable, lifesaving healthtechnologies based on wherethey live. This is a […]

  • Thai and Swiss civil society unite to protect access to medicines and the Universal  Health Coverage Scheme

    Thai and Swiss civil society unite to protect access to medicines and the Universal  Health Coverage Scheme

      Jointly, they called on the Thai government to be firm in its stance against TRIPS+  provisions during free trade agreement (FTA) negotiations with the European Free Trade Association (EFTA) This week (16 October 2024), a ministerial meeting was held between the European Free Trade Association (EFTA) and Thailand, to discuss the Free Trade Agreement […]

  • Thai HIV Advocacy Group Challenges Gilead’s and Janssen’s Patent Extension Bid, Citing Evergreening Tactics

    Thai HIV Advocacy Group Challenges Gilead’s and Janssen’s Patent Extension Bid, Citing Evergreening Tactics

    The Thai Network of People Living with HIV/AIDS (TNP+) filed an opposition to a patent application filed by the U.S.-based pharmaceutical giant Gilead Sciences and Ireland-based Janssen for the combination of rilpivirine (RPV) and tenofovir disoproxil fumarate (TDF). The big pharma companies are seeking to extend its patent monopoly on the drug combination until 2031.  […]

  • MMA Partner VNP+ Opposes Patent Application Which Would Limit Access to Long-Acting Cabotegravir 

    MMA Partner VNP+ Opposes Patent Application Which Would Limit Access to Long-Acting Cabotegravir 

    Vietnam’s Network of People Living With HIV (VNP+), a Make Medicines Affordable (MMA) partner, is working to improve access to, and affordability of long-acting HIV prevention and treatment. In September 2024, VNP+ filed a pre-grant opposition to  a patent application on long-acting cabotegravir (CAB-LA), an injectable antiretroviral recommended by the World Health Organization (WHO) for […]

  • Global South Leaders Condemn Gilead’s Restrictive License on HIV Prevention Breakthrough 

    Global South Leaders Condemn Gilead’s Restrictive License on HIV Prevention Breakthrough 

    Civil society organizations across the Global South are blasting the U.S.-based pharmaceutical company Gilead Sciences for its lenacapavir (LEN) voluntary license (VL), which allows six pharmaceutical manufacturers to make and sell generic LEN in 120 countries. All other countries must purchase LEN from Gilead, at whatever price the company chooses to set, because the generics […]

  • Indonesian Civil Society Groups Raise Alarm on how Patent Amendments Favor Big Pharma Over the Public Interests 

    Indonesian Civil Society Groups Raise Alarm on how Patent Amendments Favor Big Pharma Over the Public Interests 

    Civil society groups in Indonesia have raised concerns over proposed amendments to the Patent Law, which they argue serve the interests of pharmaceutical companies at the expense of public health in Indonesia. The Make Medicines Affordable campaign, represented by the Indonesia AIDS Coalition (IAC), along with Indonesia for Global Justice (IGJ) and the Coalition for […]